Tier 2 — strong

Effects of short-term quercetin supplementation on soldier performance

Marilyn A Sharp, Nathan R Hendrickson, Jeffery S Staab, Holly L McClung, Bradley C Nindl, Bozena B Michniak-Kohn
Journal of strength and conditioning research 2012 26 Suppl 2:S53

Bibliography

PubMed
PMID 22614228
Funding
Funding was not specified in the indexed record or the disclosure metadata available for this entry.
Competing interests
A competing-interest declaration was not available in the indexed record or the disclosure metadata used for this entry.

Study snapshot

DesignDouble-blind placebo-controlled crossover performance trial
ModelHuman intervention research
Sample16 male soldiers
InterventionQuercetin 1,000 mg/day in energy bars or placebo
Duration8.5 days per condition
EndpointsExercise performance or recovery

What the study showed, in plain terms

Published in 2012, this source examined exercise and recovery. Design: Double-blind placebo-controlled crossover performance trial. Sample/model: 16 male soldiers. The exposure or intervention was Quercetin 1,000 mg/day in energy bars or placebo. Follow-up or treatment period: 8.5 days per condition.

Oxygen uptake, loaded-march responses, cycling time-trial performance, and perceived exertion did not improve.

Short male-only military study. Increased plasma quercetin did not produce measurable performance benefit under the tested schedule.

Continue with Quercetin Data Center

For topic-level interpretation, read Quercetin for Exercise: Performance, Recovery and Muscle. This is a related guide; the citation panel separately identifies articles that directly cite this paper.

Key findings

  • Oxygen uptake, loaded-march responses, cycling time-trial performance, and perceived exertion did not improve.
  • The recorded outcome domains were Exercise performance or recovery.
  • The result applies to the tested exposure: Quercetin 1,000 mg/day in energy bars or placebo; 8.5 days per condition.

What this study can and cannot tell us

  • Short male-only military study. Increased plasma quercetin did not produce measurable performance benefit under the tested schedule.
  • An individual controlled trial must be interpreted alongside its comparator, sample size, endpoint selection and independent replication. It does not validate a different commercial formulation or a general longevity claim.
  • Source basis: Source check: PubMed abstract and indexed metadata; full methods were not independently confirmed for this entry. Missing method details, funding information or participant denominators are not inferred.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified